Biocon Ltd. NSE: BIOCON | BSE: 532523

Mid-range Performer

363.70 6.85 (1.92%)

2.5M

NSE+BSE Volume

NSE 05 Sep, 2025 3:31 PM (IST)

US FDA Observation

Biocon gets Form 483 with 5 observations from the US FDA for its Bengaluru drug substance facility See details

Detailed Stock Analysis for Biocon Ltd. with Real-time Stock Report